Also, while performing the survival analysis of breast cancer, models revealed elevated hazard ratios for the HER2-enriched and LumB subtypes, suggesting poorer survival relative to the reference group, and LumA exhibited a trend toward better survival outcomes. Here, ERBB2 is linked to breast cancer.